ConductScience.org, home

Paper20175765

Systematic review: the association between obesity and hepatocellular carcinoma - epidemiological evidence.

Saunders D and 3 others. Aliment Pharmacol Ther, 2010. Cited by 87 papers, by iCite.

Cite this record

ConductScience Library. Systematic review: the association between obesity and hepatocellular carcinoma - epidemiological evidence. Papers, record 20175765. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20175765

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Systematic review: the association between obesity and hepatocellular carcinoma - epidemiological evidence.
PubMed
Journal
Aliment Pharmacol Ther
PubMed
Year
2010
PubMed
Publication types
Journal Article, Systematic Review
PubMed
Citations, by iCite
87
iCite
Relative citation ratio, by iCite
2.25
iCite
Revised in PubMed
2025-06-26
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Saunders DD
2Seidel DD
3Allison MM
4Lyratzopoulos GG

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, HepatocellularMajor topic
Liver NeoplasmsMajor topic
ObesityMajor topic
Adolescent
Adult
Aged
Aged, 80 and over
Body Mass Index
Female
Humans
Male
Middle Aged
Risk Factors
Young Adult

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT04455932HCC Surveillance: Comparison of Abbreviated Non-contrast MRI and Ultrasound Surveillance in Cirrhotic Patients With Suboptimal Ultrasound VisualisationResults

Source ClinicalTrials.gov

Download CSV of trials

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in20636625Role of IL-6 activated STAT3 and TNF expression in obesity-associated hepatocellular carcinoma.https://conductscience.org/library/papers/20636625

Source PubMed

Download CSV of comments and corrections

Cited by47

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 87 citations.

PMIDTitleJournalYearIn PapersSource
40168281Association of overweight/obesity and digestive system cancers: A meta-analysis and trial sequential analysis of prospective cohort studies.PLoS One2025https://conductscience.org/library/papers/40168281PubMed
40144468Impact of Diabetes Mellitus and Obesity Comorbidities on Survival Outcomes after Hepatocellular Carcinoma Resection: A Multicenter Retrospective Study.Liver Cancer2025https://conductscience.org/library/papers/40144468PubMed
39867264Risk and Prognosis of Hepatocellular Carcinoma in Mexican Americans with Type 2 Diabetes Mellitus.J Hepatocell Carcinoma2025https://conductscience.org/library/papers/39867264PubMed
39733406Factors Associated with Hepatocellular Carcinoma among Patients Receiving Treatment at the National Cancer Institute, Thailand: A Case-Control Study.Asian Pac J Cancer Prev2024https://conductscience.org/library/papers/39733406PubMed
39474397Impact of baseline body mass index on the long-term prognosis of advanced hepatocellular carcinoma treated with immunotherapy.World J Gastroenterol2024https://conductscience.org/library/papers/39474397PubMed
38929668The Impact of Metabolic Health and Obesity on Liver Transplant Candidates and Recipients.Life (Basel)2024https://conductscience.org/library/papers/38929668PubMed
37429366Incidence and Risk Factors for Hepatocellular Carcinoma in Cirrhosis: The Multicenter Hepatocellular Carcinoma Early Detection Strategy (HEDS) Study.Gastroenterology2023https://conductscience.org/library/papers/37429366PubMed
36714595Overweight/obesity-related transcriptomic signature as a correlate of clinical outcome, immune microenvironment, and treatment response in hepatocellular carcinoma.Front Endocrinol (Lausanne)2022https://conductscience.org/library/papers/36714595PubMed
36687124Screening and interventions to prevent nonalcoholic fatty liver disease/nonalcoholic steatohepatitis-associated hepatocellular carcinoma.World J Gastroenterol2023https://conductscience.org/library/papers/36687124PubMed
35818404Understanding the Role of Metabolic Syndrome as a Risk Factor for Hepatocellular Carcinoma.J Hepatocell Carcinoma2022https://conductscience.org/library/papers/35818404PubMed
35269779Synergistic and Detrimental Effects of Alcohol Intake on Progression of Liver Steatosis.Int J Mol Sci2022https://conductscience.org/library/papers/35269779PubMed
35130416Cause of death and cause-specific mortality for primary liver cancer in South Korea: A nationwide population-based study in hepatitis B virus-endemic area.Clin Mol Hepatol2022https://conductscience.org/library/papers/35130416PubMed
34888493The role of NK cells in oncolytic viral therapy: a focus on hepatocellular carcinoma.J Transl Genet Genom2021https://conductscience.org/library/papers/34888493PubMed
33513939Sex Differences in the Incidence of Obesity-Related Gastrointestinal Cancer.Int J Mol Sci2021https://conductscience.org/library/papers/33513939PubMed
33349658Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention.Nat Rev Gastroenterol Hepatol2021https://conductscience.org/library/papers/33349658PubMed
31988864Hepatocellular Carcinoma in Asia: A Challenging Situation.Euroasian J Hepatogastroenterol2019https://conductscience.org/library/papers/31988864PubMed
31853685HCC screening: assessment of an abbreviated non-contrast MRI protocol.Eur Radiol Exp2019https://conductscience.org/library/papers/31853685PubMed
31781900Transarterial chemoembolization for hepatocellular carcinoma: quality of life, tumour response, safety and survival comparing two types of drug-eluting beads.Abdom Radiol (NY)2020https://conductscience.org/library/papers/31781900PubMed
31244307Significance of Serum Adiponectin and Insulin Resistance Levels in Diagnosis of Egyptian Patients with Chronic Liver Disease and HCC.Asian Pac J Cancer Prev2019https://conductscience.org/library/papers/31244307PubMed
30873458Obesity and diabetes accelerate hepatocarcinogenesis via hepatocyte proliferation independent of NF-κB or Akt/mTORC1.J Clin Transl Res2016https://conductscience.org/library/papers/30873458PubMed

See all 47 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20175765

GET https://conductscience.org/api/papers/v1/20175765/cited_by?page=2